Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$27,000.00
RATIO:Reversing the Effects of Antithrombotics using Intralipid and other molecules
EF 2024-25
Résumé
Cardiovascular diseases (CVDs), including heart disease and stroke, are leading causes of death worldwide, often resulting in thrombosis, or harmful blood clots. To prevent clots, many patients with CVD are treated with antithrombotic medications, such as anticoagulants and antiplatelets. While these drugs are effective at reducing the risk of heart attacks and strokes, they also increase the risk of bleeding. In emergencies like surgery or severe bleeding, it becomes critical to reverse the effects of these medications, but current options are limited.Currently, the main way to address bleeding in patients on antithrombotic drugs is through platelet transfusions. However, this approach is not always effective, especially when the drugs have longer-lasting effects. One promising alternative is lipid emulsions like Intralipid, which are already used to treat drug overdoses. These lipid emulsions can absorb lipophilic (fat-soluble) drugs from the bloodstream, potentially reducing their effects. Additionally, albumin, a naturally occurring protein in the blood, could also play a role by interacting with both fat-soluble and water-soluble drugs.This study will explore whether lipid emulsions and albumin can effectively reverse the anticoagulant and anti-platelet effects of commonly used drugs. We will use standard platelet function and blood clotting tests to measure how these treatments influence coagulation. The goal is to identify safe and effective strategies to restore normal blood clotting in patients at high risk of bleeding. This research could lead to new treatment options that improve the safety of patients on blood-thinning medications and reduce the risks associated with emergency situations.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
530276
Name
Tran John D
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
RATIO:Reversing the Effects of Antithrombotics using Intralipid and other molecules
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Albumin; Anti-Platelet Reversal; Antithrombotics; Cardiovascular Disease; Coagulation; Dapt; Intralipid; Thromboelastography; Ticagrelor
Abstract
Cardiovascular diseases (CVDs), including heart disease and stroke, are leading causes of death worldwide, often resulting in thrombosis, or harmful blood clots. To prevent clots, many patients with CVD are treated with antithrombotic medications, such as anticoagulants and antiplatelets. While these drugs are effective at reducing the risk of heart attacks and strokes, they also increase the risk of bleeding. In emergencies like surgery or severe bleeding, it becomes critical to reverse the effects of these medications, but current options are limited.Currently, the main way to address bleeding in patients on antithrombotic drugs is through platelet transfusions. However, this approach is not always effective, especially when the drugs have longer-lasting effects. One promising alternative is lipid emulsions like Intralipid, which are already used to treat drug overdoses. These lipid emulsions can absorb lipophilic (fat-soluble) drugs from the bloodstream, potentially reducing their effects. Additionally, albumin, a naturally occurring protein in the blood, could also play a role by interacting with both fat-soluble and water-soluble drugs.This study will explore whether lipid emulsions and albumin can effectively reverse the anticoagulant and anti-platelet effects of commonly used drugs. We will use standard platelet function and blood clotting tests to measure how these treatments influence coagulation. The goal is to identify safe and effective strategies to restore normal blood clotting in patients at high risk of bleeding. This research could lead to new treatment options that improve the safety of patients on blood-thinning medications and reduce the risks associated with emergency situations.
Competitiondate
202412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Tran, John D
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~